Covaxin
Covaxin (pronounced: koh-vax-in) is an inactivated vaccine used for the prevention of the coronavirus disease 2019 (COVID-19) in individuals 18 years of age and older.
Etymology
The name "Covaxin" is a portmanteau of "COVID-19" and "vaccine". "COVID-19" is an acronym derived from "coronavirus disease 2019", the disease that the vaccine is designed to protect against. The term "vaccine" comes from the Latin vaccinus, meaning "of or from the cow", referencing the early method of vaccination which involved cowpox.
Development
Covaxin was developed by Bharat Biotech, an Indian biotechnology company, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The vaccine is based on an inactivated form of the SARS-CoV-2 virus, which is the virus that causes COVID-19.
Efficacy
Covaxin has been shown to be effective in preventing COVID-19 in clinical trials. The vaccine has been granted emergency use authorization in India and several other countries.
Dosage and Administration
Covaxin is administered as an intramuscular injection. The recommended dosage is two doses given four weeks apart.
Side Effects
Common side effects of Covaxin include pain at the injection site, headache, fatigue, and fever. Serious side effects are rare.
Related Terms
- Vaccine
- COVID-19
- SARS-CoV-2
- Bharat Biotech
- Indian Council of Medical Research
- National Institute of Virology
External links
- Medical encyclopedia article on Covaxin
- Wikipedia's article - Covaxin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski